ConductScience.org, home

Paper28292559

Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.

Vermeulen MA and 14 others. Eur J Cancer, 2017. Cited by 70 papers, by iCite.

Cite this record

ConductScience Library. Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. Papers, record 28292559. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28292559

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.
PubMed
Journal
Eur J Cancer
PubMed
Year
2017
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
70
iCite
Relative citation ratio, by iCite
2.46
iCite
Revised in PubMed
2017-12-30
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vermeulen MAMarijn A
2Slaets LLeen
3Cardoso FFatima
4Giordano SHSharon H
5Tryfonidis KKonstantinos
6van Diest PJPaul J
7Dijkstra NHNizet H
8Schröder CPCarolien P
9van Asperen CJChristi J
10Linderholm BBarbro
11Benstead KKim
12Foekens RRenee
13Martens JWMJohn W M
14Bartlett JMSJohn M S
15van Deurzen CHMCarolien H M

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast Neoplasms, MaleMajor topic
CarcinomaMajor topic
Aged
Biomarkers, Tumor
Carcinoma, Ductal, Breast
Carcinoma, Lobular
Fibrosis
Humans
Immunohistochemistry
Lymphocytes, Tumor-Infiltrating
Male
Middle Aged
Mitotic Index
Prognosis
Survival Analysis

Source PubMed

Download CSV of topics

Cited by39

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.

PMIDTitleJournalYearIn PapersSource
42882846Histological Subtype Provides Limited Prognostic Information in Grade 1 Invasive Breast Carcinoma: A Retrospective Cohort Study.Cancers (Basel)2026https://conductscience.org/library/papers/42882846PubMed
41947199Transcriptomic deconvolution reveals prognostic immune signatures and immunotherapy-responsive subtypes in male breast cancer.Breast Cancer Res2026https://conductscience.org/library/papers/41947199PubMed
41575527Validation of IHC4 + C for male breast cancer.Virchows Arch2026https://conductscience.org/library/papers/41575527PubMed
41097794Current Perspectives on Non-Metastatic Male Breast Cancer: Genetics, Biology, and Treatment Advances: A Systematic Review.Cancers (Basel)2025https://conductscience.org/library/papers/41097794PubMed
40234892Redefining therapeutic landscapes: clinicopathological insights into low and ultra-low HER2 expression in male breast cancer.Diagn Pathol2025https://conductscience.org/library/papers/40234892PubMed
39377609Trends and efficacy of omitting axillary lymph node dissection in early-stage male breast cancer with limited nodal involvement: A population-based cohort study.Cancer Med2024https://conductscience.org/library/papers/39377609PubMed
39365001Clinicopathologic Features and Prognoses of Male Patients With Breast Cancer.Am J Mens Health2024https://conductscience.org/library/papers/39365001PubMed
39095633Influence of tumour grade on disease survival in male breast cancer patients: a systematic review.Breast Cancer Res Treat2024https://conductscience.org/library/papers/39095633PubMed
38339299HER2-Low Expression in Male Breast Cancer: Results from a Multicenter Series in Italy.Cancers (Basel)2024https://conductscience.org/library/papers/38339299PubMed
37085843The prediction of distant metastasis risk for male breast cancer patients based on an interpretable machine learning model.BMC Med Inform Decis Mak2023https://conductscience.org/library/papers/37085843PubMed
36614261Tumor Microenvironment in Male Breast Carcinoma with Emphasis on Tumor Infiltrating Lymphocytes and PD-L1 Expression.Int J Mol Sci2023https://conductscience.org/library/papers/36614261PubMed
35695928Tumor budding and fibrotic focus-proposed grading system for tumor budding in invasive carcinoma no special type of the breast.Virchows Arch2022https://conductscience.org/library/papers/35695928PubMed
35181590High-throughput Proteomic Profiling of Male Breast Cancer Tissue.Cancer Genomics Proteomics2022https://conductscience.org/library/papers/35181590PubMed
35117121Intracystic papillary breast carcinoma with DCIS in a man: a case report.Transl Cancer Res2019https://conductscience.org/library/papers/35117121PubMed
34733614A biomarker study in Peruvian males with breast cancer.World J Clin Oncol2021https://conductscience.org/library/papers/34733614PubMed
34572741Transcriptome of Male Breast Cancer Matched with Germline Profiling Reveals Novel Molecular Subtypes with Possible Clinical Relevance.Cancers (Basel)2021https://conductscience.org/library/papers/34572741PubMed
34458944Male breast cancer: an update.Virchows Arch2022https://conductscience.org/library/papers/34458944PubMed
34079019Comparison between male and female breast cancer survival using propensity score matching analysis.Sci Rep2021https://conductscience.org/library/papers/34079019PubMed
33991247Prognostic relevance of Ki67 expression in primary male breast cancer: determination of cut-off points by different evaluation methods and statistical examinations.J Cancer Res Clin Oncol2022https://conductscience.org/library/papers/33991247PubMed
33974127Cytoplasmic DDX3 as prognosticator in male breast cancer.Virchows Arch2021https://conductscience.org/library/papers/33974127PubMed

See all 39 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28292559

GET https://conductscience.org/api/papers/v1/28292559/cited_by?page=2